Archive for January, 2009

Working Together on a Novel Stent System

Friday, January 30th, 2009

[caption id="attachment_4092" align="alignleft" width="347" caption="The Finale coating is designed to accelerate the healing process following stenting. The photo on the left show histology demonstrating 100% cell coverage. On the right, a functional endothelium via CD-31 antibody staining is shown at two weeks in a preclinical model."][/caption] From the Wire: This novel ...

A New Partnership in Testing

Friday, January 30th, 2009

From its testing laboratory in Marseille, France, Protomed will use Machine Solutions Inc's (MSI) interventional device testing equipment and its radial expansion force testing equipment. The partnership will expand MSI’s reach into the European catheter, stent and emerging minimally invasive medical device markets. Frédéric Mouret, Chief Executive Officer and Founder of ...

Scientists Tout Progress Toward Building Artificial Neurons

Thursday, January 29th, 2009

[caption id="attachment_4053" align="alignright" width="350" caption="The image above depicts an artist's depiction of a carbon nanotube synapse. Image courtesy: Khushnood Irani and Alice Parker."][/caption] Researchers at the University of Southern California (USC) have succeeded in creating synthetic neurons using carbon nanotubes. The individual neurons--though primitive--have excitatory and inhibitory synapses. USC professors Alice ...

Tremendous Growth Predicted for Low-End Ultrasound

Thursday, January 29th, 2009

The Eastern European market currently offers lucrative opportunities to an increasing number of market participants, according to analysis from Frost & Sullivan. Its report states that this market earned revenues of US$197.2 million in 2007 and estimates that it will reach $370.9 million in 2014. “Volume sales in Eastern European markets ...

Look Who Is Going Shopping

Wednesday, January 28th, 2009

Abbott Laboratories, with US$3.77 billion in cash, is seeking to buy nonpharmaceutical companies beaten down by the recession, reports Bloomberg’s Tom Randall. Abbott, which manufactures insulin pumps and heart stents, is browsing small and medium sized companies that make medical technology products. Its Chief Executive Officer Miles White, is reported as ...

New Computer Model Simulates Drug-Eluting Stent Behaviour In Vivo

Tuesday, January 27th, 2009

[caption id="attachment_3999" align="alignleft" width="350" caption="Taken from MIT’s computer-modeling software, this image shows the arterial drug distribution patterns for three different scenarios of drug release in a single stent. Blood flow in this 3-D simulation is from left to right. Red represents the highest concentration of drug release and blue represents ...

RTP Sheet and Film Division Acquires Extruder

Tuesday, January 27th, 2009

[caption id="attachment_4040" align="alignright" width="250" caption="By acquiring Omnova Solutions, Wiman Corp. aims to diversify its production and add capacity to produce 1-mil grades."][/caption] Engineered thermoplastics compounder RTP Co. (Winona, MN, USA) announced yesterday that its sheet and film subsidiary Wiman Corp. has purchased extruder Omnova Solutions (Dupo, IL, USA). Based in Sauk ...

Being One of the 100 Best Companies to Work For

Tuesday, January 27th, 2009

For the 12th consecutive year, W. L. Gore & Associates Inc. has earned a place in FORTUNE magazine’s list of the “100 Best Companies to Work For.” Gore is ranked 15th. According to the magazine, a driving factor for the companies on this year’s list is that they excel at ...

Life Sciences CEOs Offer Advice to President Obama

Monday, January 26th, 2009

What can President Barack Obama do to help the life sciences sector thrive? Mass High Tech, a journal devoted to high technology business news in the New England states, posed that question to a handful of CEOs from life science companies just a few days prior to Obama’s inauguration. Almost ...

Course at Cranfield University Dedicated to US Regulation of Medical Technology

Friday, January 23rd, 2009

Scheduled for February 24–26, a course developed by Cranfield University in collaboration with TOPRA will examine how US regulatory procedures are applied to medical technologies. Offered by Cranfield University in the United Kingdom, the course is designed to enable attendees to leave with the capability to advise their organizations about ...

Is Health Care Employing Too Many Stents?

Friday, January 23rd, 2009

From the wire: Fewer deaths, heart attacks and repeat procedures occurred when doctors implanted fewer stents and employed a blood flow test to decide when they were truly needed, found a study published in the New England Journal of Medicine. In a news report of the study, Marilynn Marchione writes, the ...

To Test or Not to Test: Defibrillation Testing Trial Begins

Friday, January 23rd, 2009

The Shockless Implant Evaluation (SIMPLE ) study, being conducted by Boston Scientific, is an international, multicentred clinical trial designed to evaluate the need for defibrillation testing. Currently, this testing remains part of the recommended procedure for cardioverter defibrillator (ICD) implantation, to check system integrity, appropriate sensing of ventricular tachyarrhythmia and ...